MBI Trustee Spotlight: Charles Kunsch

Charles Kunsch, Vice Chair of the MBI Board of Trustees, is a distinguished leader in life sciences, known for his expertise in venture strategy and advancing innovative biotech companies. With a robust background that includes his role at AbbVie Ventures and his current position as Managing Partner at Ballastone Life Science Advisors, Charles brings unparalleled insight and guidance to MBI’s mission of fostering the life sciences cluster in Central Massachusetts.

At AbbVie, Charles was instrumental in identifying and investing in groundbreaking biotech startups. His work played a crucial role in advancing the next generation of life sciences, supporting both emerging technologies and their potential impact on healthcare. Now, as Managing Partner at Ballastone Life Science Advisors, Chuck applies his strategic vision and operational acumen to help life sciences companies navigate complex market landscapes, optimize their growth strategies, and achieve long-term sustainability.

Charles Kunsch’s involvement with MBI amplifies his commitment to fostering regional innovation and supporting the entrepreneurial ecosystem in Central Massachusetts. His experience in both investment and advisory roles makes him a vital asset to MBI as the organization works to strengthen the infrastructure for life sciences startups, catalyze biomanufacturing innovation, and build pathways for sustainable economic development.